Xuan Dong
Wuhan Jinyintan Hospital
8 Papers
5 Citations
Xuan Dong is an academic researcher from Wuhan Jinyintan Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen,Min Zhou,Xuan Dong,Jie-Ming Qu,Fengyun Gong,Yang Han,Yang Qiu,Jingli Wang,Ying Liu,Yuan Wei,Jia'an Xia,Ting Yu,Xinxin Zhang,Li Zhang +13 more
TL;DR: Characteristics of patients who died were in line with the MuLBSTA score, an early warning model for predicting mortality in viral pneumonia, and further investigation is needed to explore the applicability of the Mu LBSTA scores in predicting the risk of mortality in 2019-nCoV infection.
22.6K
Epidemiological and Clinical Characteristics of 99 Cases of 2019-Novel Coronavirus (2019-nCoV) Pneumonia in Wuhan, China
Nanshan Chen,Min Zhou,Xuan Dong,Jieming Qu,Fengyun Gong,Yang Han,Yang Qiu,Jingli Wang,Ying Liu,Yuan Wei,Jia'an Xia,Ting Yu,Xinxin Zhang,Li Zhang +13 more
TL;DR: Early diagnosis, early isolation, multiple treatment, and intervention of CRRT and ECMO when necessary can effectively reduce mortality caused by severe coronavirus pneumonia.
65
COVID‐19 associated EBV reactivation and effects of ganciclovir treatment
Mei Meng,Sheng-Ping Zhang,Xuan Dong,Wenqing Sun,Yunfeng Deng,Wenzhe Li,Ranran Li,Djillali Annane,Zhixiong Wu,Dechang Chen +9 more
TL;DR: Systemic reactivation of Epstein–Barr virus (EBV) may occur in novel coronavirus disease 2019 (COVID‐19) caused by the severe acute respiratory syndrome coronvirus‐2 (SARS‐CoV‐2) but the clinical consequences remain uncertain.
The mncp-spi score predicting risk of severe covid-19 among mild-pneumonia patients on admission
Lingxi Guo,Weining Xiong,Dong Liu,Yun Feng,Peng Wang,Xuan Dong,Rong Chen,Yi Wang,Lei Zhang,Jingwen Huang,Hanssa Dwarka Summah,Fang-Ying Lu,Yusang Xie,Huihuang Lin,Jiayang Yan,Hongzhou Lu,Min Zhou,Jieming Qu +17 more
TL;DR: A clinical predictive tool for risk of severe pneumonia among mNCP patients to provided guidance for medicines is designed and required for external validation.
A trial of arbidol hydrochloride in adults with COVID-19
Jing Zhao,Jin-Nong Zhang,Yang Jin,Zhouping Tang,Ke Hu,Hui Sun,Meng-Meng Shi,Peiyu Gu,Hongrong Guo,Qi Li,Haiying Zhang,Chenghong Li,Mingming Yang,Nian Xiong,Xuan Dong,Juanjuan Xu,Fan Lin,Tao Wang,Chao Yang,B. K. Huang,Jingyi Zhang,Shi Chen,Qiong He,Min Zhou,Jie-Ming Qu +24 more
TL;DR: SOC plus arbidol tablets significantly increase the negative conversion rate of SARS-CoV-2 within the first week and accelerate the recovery of COVID-19 patients.
4